Literature DB >> 30343719

Racial and Ethnic Disparities in the Obesity Paradox.

Carola-Ellen Kleine1, Hamid Moradi2, Elani Streja3, Kamyar Kalantar-Zadeh4.   

Abstract

Obesity is a major risk factor for cardiovascular disease and worse survival in the general population. However, in patients with end-stage renal disease (ESRD), higher body mass index and indexes of body fat and muscle are associated with better survival. Furthermore, these associations, which some have described as the obesity paradox, are more consistent in African American patients being treated with hemodialysis when compared with other racial-ethnic groups. This is in view of data indicating that although the rate of progression to ESRD is faster in African American patients, they have a survival advantage after transition to ESRD when compared with their white counterparts. These observations indicate that there may be significant interaction between race/ethnicity and association of body mass index with outcomes in patients with ESRD. In addition, it is possible that mechanisms underlying improved survival in African American hemodialysis patients are partly related to the association of body mass index with outcomes observed in this patient population. Some of these potential mechanisms may include comparatively reduced risk for protein-energy wasting and malnutrition, possible salutary effects of factors that play a role in energy preservation, resistance to deleterious effects of inflammation, and enhanced muscle mass and body composition. Given that ESRD is associated with significantly increased risk for morbidity and mortality, understanding the pathophysiologic mechanisms responsible for the obesity paradox across race-ethnic populations might help identify potential therapeutic targets that can be used to improve survival in this patient population. Published by Elsevier Inc.

Entities:  

Keywords:  Obesity paradox; adipose tissue; body composition; body mass index (BMI); cardiovascular diseases; end-stage renal disease (ESRD); ethnic groups; ethnicity; inflammation; malnutrition; mortality; race; review; risk factors; survival

Mesh:

Year:  2018        PMID: 30343719     DOI: 10.1053/j.ajkd.2018.06.024

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Circulating Endocannabinoids and Mortality in Hemodialysis Patients.

Authors:  Hamid Moradi; Christina Park; Elani Streja; Donovan A Argueta; Nicholas V DiPatrizio; Amy S You; Connie M Rhee; Nosratola D Vaziri; Kamyar Kalantar-Zadeh; Daniele Piomelli
Journal:  Am J Nephrol       Date:  2020-01-14       Impact factor: 3.754

2.  How much abdominal fat do obese patients lose short term after laparoscopic sleeve gastrectomy? A quantitative study evaluated with MRI.

Authors:  Jing Sun; Han Lv; Mengyi Li; Lei Zhao; Yawen Liu; Na Zeng; Xuan Wei; Qian Chen; Pengling Ren; Yang Liu; Peng Zhang; Zhenghan Yang; Zhongtao Zhang; Zhenchang Wang
Journal:  Quant Imaging Med Surg       Date:  2021-11

3.  In-Hospital Outcomes of Coronary Artery Stenting in Patients With ST-Elevation Myocardial Infarction (STEMI) and Metabolic Syndrome: Insights From the National Inpatient Sample.

Authors:  Owen Igbinosa; Ahmed Brgdar; Joseph Asemota; Mohamed E Taha; Jin Yi; Anthony Lyonga Ngonge; Swati Vanaparthy; Raccquel Hammonds; Joseph Talbet; Diannemarie Omire-Mayor; Julius Ngwa; Muhammad Rizwan; Mehrotra Prafulla; Isaac Opoku
Journal:  Cureus       Date:  2022-05-02

Review 4.  Flawed methods and inappropriate conclusions for health policy on overweight and obesity: the Global BMI Mortality Collaboration meta-analysis.

Authors:  Katherine M Flegal; John P A Ioannidis; Wolfram Doehner
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-01-17       Impact factor: 12.910

5.  Impact of Percent Body Fat on All-Cause Mortality among Adequate Dialysis Patients with and without Insulin Resistance: A Multi-Center Prospective Cohort Study.

Authors:  Tuyen Van Duong; Te-Chih Wong; Hsi-Hsien Chen; Tso-Hsiao Chen; Yung-Ho Hsu; Sheng-Jeng Peng; Ko-Lin Kuo; Hsiang-Chung Liu; En-Tzu Lin; Shwu-Huey Yang
Journal:  Nutrients       Date:  2019-06-09       Impact factor: 5.717

6.  Obesity and Morbidity Risk in the U.S. Veteran.

Authors:  Jose A Betancourt; Paula Stigler Granados; Gerardo J Pacheco; Ramalingam Shanmugam; C Scott Kruse; Lawrence V Fulton
Journal:  Healthcare (Basel)       Date:  2020-06-29

7.  MCH-R1 Antagonist GPS18169, a Pseudopeptide, Is a Peripheral Anti-Obesity Agent in Mice.

Authors:  Jean A Boutin; Magali Jullian; Lukasz Frankiewicz; Mathieu Galibert; Philippe Gloanec; Thierry Le Diguarher; Philippe Dupuis; Amber Ko; Laurent Ripoll; Marc Bertrand; Anne Pecquery; Gilles Ferry; Karine Puget
Journal:  Molecules       Date:  2021-02-27       Impact factor: 4.411

8.  Disparities in Cardiovascular Disease Outcomes Among Pregnant and Post-Partum Women.

Authors:  Mohamed M Gad; Islam Y Elgendy; Ahmed N Mahmoud; Anas M Saad; Toshiaki Isogai; Isadora Sande Mathias; Rabel Misbah Rameez; Johnny Chahine; Hani Jneid; Samir R Kapadia
Journal:  J Am Heart Assoc       Date:  2020-12-16       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.